Table 1 General patient information
From: Non-invasive skin cholesterol testing: a potential proxy for LDL-C and apoB serum measurements
|  | Group I (n=53) | Group II (n=68) | t/χ2 | P |
|---|---|---|---|---|
Age (years old) | 56.43±13.23 | 62.26±13.00 | 2.429 | 0.017 |
Male (n/%) | 40(75.47 %) | 56(82.35 %) | 0.860 | 0.241 |
Male smokers (n/%) | 24(45.28 %) | 22(39.29 %) | 4.012 | 0.036 |
History of hypertension (n/%) | 30(56.60 %) | 34(50.00 %) | 0.521 | 0.295 |
TG (mmol/L) | 2.25±2.04 | 1.44±0.51 | 3.991 | <0.001 |
HDL-C (mmol/L) | 0.88±0.20 | 0.91±0.26 | -0.745 | 0.458 |
LDL-C (mmol/L) | 3.05±1.79 | 2.64±0.87 | 1.630 | 0.106 |
number of low initial LDL-C cases(n/%) | 9(16.98 %) | 12(17.65 %) | 0.009 | 0.560 |
apoA-1 (g/L) | 1.28±0.20 | 1.26±0.22 | 0.563 | 0.574 |
apoB (g/L) | 1.01±0.48 | 0.86±0.23 | 2.329 | 0.022 |
Lp(a) (g/L) | 344.24±297.91 | 260.63±207.07 | 1.701 | 0.093 |
Initial skin cholesterol | 0.32±0.08 | 0.31±0.08 | 0.538 | 0.592 |